OTLCOncotelic Therapeutics, Inc. insider trades
In the last 90 days, 1 insider bought $23.5K of Oncotelic Therapeutics, Inc. (OTLC) on the open market and none sold. The largest purchase was $17.8K by Trieu Vuong (CHAIRMAN AND CEO) on Oct 29.
- Market cap
- $9.15M
- as of 2026-10-29
- Latest close
- $0.02
- as of 2026-10-29
- Sector
- Healthcare
- as of 2026-10-30
- Industry
- Biotechnology
- as of 2026-10-30
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-08-27
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Trieu VuongCHAIRMAN AND CEO | Oct 29 | Oct 30 | P | 1,044,990 | $0.02 | Purchase +$17,765 | 95,481,309 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Oct 28 | Oct 30 | P | 312,000 | $0.02 | Purchase +$5,772 | 94,436,319 | No | Form 4 |
| Fein Seymour HowardCRO/CMO | Jul 10 | Jul 23 | A · derivative | 250 | $0.00 | $0 | 250 | No | Form 4 |
| King Steven W | Jul 10 | Jul 21 | A · derivative | 250 | $0.00 | $0 | 250 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jul 10 | Jul 14 | A · derivative | 2,000 | $0.00 | $0 | 2,000 | No | Form 4 |
| Shah Amit B.CFO | Jul 10 | Jul 14 | A · derivative | 1,500 | $0.00 | $0 | 1,500 | No | Form 4 |
| Saund SaranCBO | Jul 10 | Jul 14 | A · derivative | 1,500 | $0.00 | $0 | 1,500 | No | Form 4 |
| Maida Anthony E IIIDIRECTOR AND CMO - TRANS. MED. | Jul 10 | Jul 14 | A · derivative | 1,500 | $0.00 | $0 | 1,500 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jul 1 | Jul 2 | P | 240,000 | $0.04 | Purchase +$9,600 | 94,124,319 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jun 24 | Jun 24 | P | 115,000 | $0.05 | Purchase +$5,750 | 93,884,319 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jun 23 | Jun 24 | P | 75,000 | $0.05 | Purchase +$3,750 | 93,769,319 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jun 22 | Jun 24 | P | 65,000 | $0.05 | Purchase +$3,250 | 93,694,319 | No | Form 4 |
| Shah Amit B.CFO | Jun 22 | Jun 22 | P | 20,000 | $0.05 | Purchase +$1,000 | 378,837 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jun 17 | Jun 17 | P | 239,759 | $0.04 | Purchase +$9,590 | 93,629,319 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jun 15 | Jun 17 | P | 96,000 | $0.05 | Purchase +$4,800 | 93,389,560 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jan 22 | Jan 26 | A · derivative | 4,426 | $0.00 | $0 | 8,491 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Nov 17, 2025 | Nov 19, 2025 | A · derivative | 4,065 | $0.00 | $0 | 4,065 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jul 10, 2025 | Jul 10, 2025 | P | 104,000 | $0.01 | Purchase +$1,040 | 93,293,560 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jul 9, 2025 | Jul 10, 2025 | P | 1 | $0.01 | Purchase +$0 | 93,293,561 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jul 8, 2025 | Jul 10, 2025 | P | 94,736 | $0.01 | Purchase +$947 | 93,388,297 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jan 31, 2025 | Jan 31, 2025 | P | 63,775 | $0.03 | Purchase +$1,913 | 93,189,560 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jan 30, 2025 | Jan 31, 2025 | P | 100,003 | $0.03 | Purchase +$3,000 | 93,125,785 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Jan 29, 2025 | Jan 31, 2025 | P | 183,066 | $0.03 | Purchase +$5,492 | 93,025,782 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Nov 22, 2024 | Nov 26, 2024 | P | 298,499 | $0.03 | Purchase +$8,955 | 92,842,716 | No | Form 4 |
| Trieu VuongCHAIRMAN AND CEO | Aug 23, 2024 | Aug 27, 2024 | P | 500,000 | $0.02 | Purchase +$10,000 | 92,544,217 | No | Form 4 |